Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: Market Pathways April-May 2026

  • 2026-04-01 00:00:00.0
  • Nancy Dvorin
  • Market Pathways

Should generative AI tools be trained, evaluated, and monitored like doctors as an alternative to regulatory oversight? The proposed RAPID pathway: designing pivotal trials that will address regulatory authorization and national Medicare coverage. The global shift from passive filing to active mining of postmarket surveillance data to identify industry trends. CMS proposes to end fast track to extra Medicare payments for breakthrough devices used in some hospital settings.

Read Article